查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1597292

採血針的全球市場的評估:各產品，各用途，各年齡層，各終端用戶，各地區，機會，預測(2017年～2031年)

Lancets Market Assessment, By Product, By Application, By Age Group, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 234 Pages | 商品交期: 3-5個工作天內

價格

全球採血針的市場規模，被預測從2023年的21億美元2031年年達到42億6,000萬美元，2024年～2031年的預測期間年複合成長率9.24％的成長被預料。市場，是根據糖尿病和貧血，白血病等的血液疾病的盛行率的增加，及定期性的健康檢查相關的意識的高漲，技術的進步，政府的配合措施正穩定成長中。採血針，為了從腳後跟，耳朵垂兒，手指等的皮膚的一部分采毛細血管的血液樣品是所使用的，小型攜帶可能的醫療設備。為了採血有那個起源，採血針的歷史波及到數千年，此後各種各樣的醫療的需求響應進化了。採血針現在，對面向了貧血診斷的血紅素的評估，轉向了糖尿病患者的葡萄糖的評估，轉動了血液凝固障礙的凝固的評估不可缺少。採血針為了用葡萄糖檢驗追蹤，尤其是糖尿病患者的血糖值被血液樣品的採取使用。

採血針，用決定血紅素層級的血紅素檢驗被使用，為了估價捐血者的申請資格被頻繁使用。採血針，被對血液樣品的採取和血液凝固能力的檢測有用的血液凝固檢驗使用。為了自我監測設備的需求高漲和，根據疼痛少的技術的開發成長被預料，採血針產業的未來明亮。另一方面，採血針市場，有根據象持續葡萄糖監測(CGM)一樣的非侵襲設備的引進受到影響的可能性。CGM系統，為了代替監測血糖值的傳統的指尖穿刺技術，方便容易使用，提供痛苦沒有的東西，在臨床現場越發變得被使用。2023年，含血糖監測儀，酮體測量儀，試紙，採血針的4個GlucoRx的測量器被新的委託推薦記載了。GlucoRx的設備，GlucoRx HCT，GlucoRx Q，GlucoRx Nexus Blue，GlucoRx 是KEYA。根據嚴格的審查次序，最高品質只成本效益的高(貴)的設備被認證的事被保證，被建議了的測量器，帶，採血針這個合格了。

本報告提供全球採血針市場相關調查分析，市場規模與預測，市場動態，提供著主要企業的形勢等資訊。

目錄

第1章 計劃的範圍和定義

第2章 調查手法

第3章 摘要整理

第4章 全球採血針市場預測(2017年～2031年)

  • 市場規模的分析與預測
    • 金額
    • 數量
  • 市場佔有率的分析與預測
    • 各產品
    • 各用途
    • 各年齡層
    • 各終端用戶
    • 各地區
    • 市場佔有率分析:各企業(金額)(前五名公司和其他 - 2023年)
  • 市場地圖分析(2023年)
    • 各產品
    • 各用途
    • 各年齡層
    • 各終端用戶
    • 各地區

第5章 北美的採血針市場預測(2017年～2031年)

  • 市場規模的分析與預測
    • 金額
    • 數量
  • 市場佔有率的分析與預測
    • 各產品
    • 各用途
    • 各年齡層
    • 各終端用戶
    • 佔有率:各國
  • 各國的市場評估
    • 美國的採血針市場預測(2017年～2031年)
    • 加拿大
    • 墨西哥

第6章 歐洲的採血針市場預測(2017年～2031年)

  • 德國
  • 法國
  • 義大利
  • 英國
  • 俄羅斯
  • 荷蘭
  • 西班牙
  • 波蘭

第7章 亞太地區的採血針市場預測(2017年～2031年)

  • 印度
  • 中國
  • 日本
  • 澳洲
  • 越南
  • 韓國
  • 印尼
  • 菲律賓

第8章 南美的採血針市場預測(2017年～2031年)

  • 巴西
  • 阿根廷

第9章 中東·非洲的採血針市場預測(2017年～2031年)

  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非
  • 以色列

第10章 供需分析

第11章 價值鏈分析

第12章 波特的五力分析

第13章 大環境分析

第14章 價格分析

第15章 市場動態

  • 推動市場要素
  • 市場課題

第16章 市場趨勢與發展

第17章 法規結構和革新

  • 臨床試驗
  • 法規當局的認證

第18章 專利形勢

第19章 案例研究

第20章 競爭情形

  • 市場領導者前五名公司的競爭矩陣
  • 前五名公司的SWOT分析
  • 主要企業前十大企業的形勢
    • HTL-Strefa S.A.
    • Terumo Medical Corporation
    • Becton Dickinson and Company
    • F.Hoffman-La Roche AG
    • B.Braun SE
    • Abbott Laboratories
    • Owen Mumford Ltd.
    • Arkray Inc
    • Bayer AG
    • Medline Industries, LP

第21章 策略性推薦

第22章 本公司相關資料，免責聲明

Product Code: MX12289

Global lancets market is projected to witness a CAGR of 9.24% during the forecast period 2024-2031F, growing from USD 2.10 billion in 2023 to USD 4.26 billion in 2031F. The lancets market is steadily growing due to the increasing prevalence of diabetes and hematologic disorders such as diabetes, anemia, and leukemia, as well as increasing awareness related to regular health checkups, technological advancements, and government initiatives. Lancets are tiny, portable medical devices that are used to take capillary blood samples from parts of the skin, such as the heels, earlobes, and fingers. With their origins in bloodletting, the history of lancets spans thousands of years, and they have since evolved to serve various healthcare needs. Lancets are now essential for evaluating hemoglobin for diagnosing anemia, glucose for diabetics, and coagulation for blood clotting problems. Lancets are used in glucose testing to draw blood samples to track blood glucose levels, particularly in diabetic patients.

Lancets are used in hemoglobin testing, which determines hemoglobin levels, and are frequently used to assess blood donors' eligibility. Lancets are used in coagulation testing to help draw blood samples and measure the blood's clotting capacity. With expected growth spurred by rising demand for self-monitoring devices and developments in low-pain technologies, the lancet industry has a bright future. On the other hand, the market for lancets may be impacted by the introduction of non-invasive equipment like continuous glucose monitoring (CGM). CGM systems are becoming increasingly used in clinical practice because they offer a convenient, easy-to-use, and painless substitute for traditional fingerstick techniques of monitoring blood sugar levels. In 2023, four GlucoRx meters were listed on new commissioning recommendations, including blood glucose monitors, ketone meters, testing strips, and lancets. The devices by GlucoRx that have been included are GlucoRx HCT, GlucoRx Q, GlucoRx Nexus Blue, and GlucoRx KEYA. A stringent review procedure ensured that only the highest-quality and cost-effective devices were certified, and the suggested meters, strips, and lancets passed it.

Increasing Prevalence of Chronic Diseases Drives Market Growth

The increasing prevalence of chronic diseases such as diabetes and blood disorders like anemia is significantly driving the market growth for lancets. Chronic diseases are ongoing, generally incurable illnesses or conditions, such as heart disease, asthma, diabetes, and blood disorders. These diseases can be prevented and managed through early detection, improved diet, exercise, and treatment therapy. Diabetes is at the center of several diseases for multiple long-term conditions and is directly or indirectly related to several other chronic conditions. As per the IDF Diabetes Atlas, in 2021, 1 out of 10 people (or 537 million people) had diabetes. By 2030, the number of people with diabetes is expected to reach 643 million and 738 million by 2045. Anemia has a significant impact on patient outcomes and is prevalent in people with diabetes and chronic kidney disease (CKD). The necessity of frequent blood sampling drives the demand and market expansion for lancets due to the requirement for ongoing monitoring and management of these illnesses.

Government Initiatives Positively Impact Market Demand

Government initiatives are significantly driving the demand for lancets. In many countries, governments are initiating efforts to improve healthcare service delivery and encourage the use of self-monitoring gadgets, hence increasing the need for lancets. Such an example can be found in the case of India, where the Union Health Ministry embarked on a process aimed at screening seventy-five million individuals suffering from hypertension or type II diabetes for necessary treatment by 2025. At the same time, the European Commission is currently working on the promotion of harmonized systems for diabetes care span across 25 provinces, including rural areas. This campaign has increased knowledge concerning routine monitoring of blood sugars; hence, there is a noticeable rise in the use of lancets alongside other tools for managing diabetes. The government of Canada is planning to initiate a fund to manage and support access to medical devices and supplies such as glucometers, test strips, and lancets to assist diabetic patients in managing and monitoring their blood sugar levels.

Safety Lancets are Expected to Dominate the Global Lancets Market

There are multiple reasons behind the growth of safety lancets; it is anticipated to gain considerable traction in the coming years due to increasing cases of chronic illnesses (for example, diabetes, hematoma, anemia), increasing need for home-based medical services and general awareness concerning the advantages associated with the use of safety lancets. All these act as drivers for its rapid expansion, while traditional lancets have a minimal edge over it in terms of clinical benefits over safety lancets. Safety lancets are designed with features that help to prevent accidental needle stick injuries, reducing the risk of infection and injury for healthcare professionals and patients. Safety lancets obtain an adequate quantity of blood with a single stick, which helps prevent wastage of strips, keeps costs down, and prevents the need to re-prick your finger. Safety lancets use high speed, offer minimum pain, prevent error, have a comfortable grip, and are ergonomically designed.

In 2021, Owen Mumford Limited introduced Unistik Touch, a high-flow safety lancet. Unistik Touch makes capillary blood sampling easy with its one-touch activation feature. Unistik Touch uses comfort zone technology (CZT) and comes in various sizes to meet blood volume requirements. In order to improve comfort when placed against the sample site during blood drawing, CZT is made up of several elevated pressure points on the patient end of the safety lancet.

Asia-Pacific is Expected to Grow at the Fastest Rate

During the forecast period, there is anticipated to be a significant need for lancets in Asia-Pacific. The rising incidence of chronic illnesses like diabetes mostly drives the demand for lancets in the region. An increase in diabetes incidence has been observed in countries such as China and India, which has increased the need for lancets and blood glucose monitoring devices. The increasing need for lancing devices is also being fueled by the region's expanding diagnostic test pool, as well as advancements in healthcare infrastructure. Furthermore, the demand for lancets to draw blood samples for testing and diagnosis is being driven by the rising prevalence of infectious illnesses in Asia-Pacific, including malaria, dengue, diabetes, and chikungunya. This region's lancet market is also driven by government programs aimed at promoting integrated healthcare systems across urban and rural areas and improving diabetes treatment.

The results of a countrywide survey published by The Lancet Diabetes & Endocrinology journal, 2023, show that 11.4% of Indians have diabetes, while 35.5% and 15.3% of persons have hypertension and prediabetes, respectively.

Future Market Scenario (2024-2031F)

The demand for lancets is expected to witness substantial growth in the future. An important factor behind the significant growth is the rising prevalence of blood disorders and diabetes, coupled with improved lancet technology to improve patient comfort and convenience. Regarding advancements, medical device manufacturers are prioritizing painless lancing devices that have adjustability on penetration depth by making patients feel better. Continuous Glucose Monitoring (CGM) systems are gaining popularity among diabetic patients. However, lancing devices and lancets remain essential for periodic calibration and confirmatory blood glucose measurements. While CGM systems provide real-time glucose readings and trend information, they still require fingerstick calibrations for accuracy, thereby sustaining the demand for lancets.

Key Players Landscape and Outlook

Several medical device companies like HTL-Strefa S.A., Terumo Medical Corporation, Becton Dickinson and Company, F.Hoffman-La Roche AG, B.Braun SE, Abbott Laboratories, Owen Mumford Ltd., Arkray Inc, Bayer AG and Medline Industries, LP are flourishing in the global lancets market by planning and adopting new strategies. They comply with new strategic initiatives for lancets to increase their market presence. New agreements, contracts, acquisitions, mergers, investments, and partnerships are major ways through which they are trying to achieve higher market share.

Leading multinational medical device company BD (Becton, Dickinson, and Company) announced in 2022 that it successfully spun out Embecta Corp. (beta), which currently owns BD's former diabetes care division and is among the biggest diabetes care companies globally. Grow, Simplify, and Empower - BD's three strategic pillars-are the foundation of the company's BD 2025 plan, which the spinoff can see of embecta. The goal of the spinoff was to split into two distinct businesses that would provide BD stockholders with significant long-term value and improved strategic, operational, and financial attributes.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Lancets Market Outlook, 2017-2031F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Product
      • 4.2.1.1. Safety Lancets
      • 4.2.1.2. Standard Lancets
      • 4.2.1.3. Specialty Lancets
      • 4.2.1.4. Others
    • 4.2.2. By Application
      • 4.2.2.1. Glucose Testing
      • 4.2.2.2. Hemoglobin Testing
      • 4.2.2.3. Cholesterol Testing
      • 4.2.2.4. Coagulation Testing
      • 4.2.2.5. Others
    • 4.2.3. By Age Group
      • 4.2.3.1. Adults
      • 4.2.3.2. Pediatric
    • 4.2.4. By End-user
      • 4.2.4.1. Hospitals
      • 4.2.4.2. Clinics
      • 4.2.4.3. Diagnostic Centers
      • 4.2.4.4. Home Care Settings
      • 4.2.4.5. Others
    • 4.2.5. By Region
      • 4.2.5.1. North America
      • 4.2.5.2. Europe
      • 4.2.5.3. Asia-Pacific
      • 4.2.5.4. South America
      • 4.2.5.5. Middle East and Africa
    • 4.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
  • 4.3. Market Map Analysis, 2023
    • 4.3.1. By Product
    • 4.3.2. By Application
    • 4.3.3. By Age Group
    • 4.3.4. By End-user
    • 4.3.5. By Region

5. North America Lancets Market Outlook, 2017-2031F*

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
    • 5.1.2. By Volume
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Product
      • 5.2.1.1. Safety Lancets
      • 5.2.1.2. Standard Lancets
      • 5.2.1.3. Specialty Lancets
      • 5.2.1.4. Others
    • 5.2.2. By Application
      • 5.2.2.1. Glucose Testing
      • 5.2.2.2. Hemoglobin Testing
      • 5.2.2.3. Cholesterol Testing
      • 5.2.2.4. Coagulation Testing
      • 5.2.2.5. Others
    • 5.2.3. By Age Group
      • 5.2.3.1. Adults
      • 5.2.3.2. Pediatric
    • 5.2.4. By End-user
      • 5.2.4.1. Hospitals
      • 5.2.4.2. Clinics
      • 5.2.4.3. Diagnostic Centers
      • 5.2.4.4. Home Care Settings
      • 5.2.4.5. Others
    • 5.2.5. By Country Share
      • 5.2.5.1. United States
      • 5.2.5.2. Canada
      • 5.2.5.3. Mexico
  • 5.3. Country Market Assessment
    • 5.3.1. United States Lancets Market Outlook, 2017-2031F*
      • 5.3.1.1. Market Size Analysis & Forecast
        • 5.3.1.1.1. By Value
        • 5.3.1.1.2. By Volume
      • 5.3.1.2. Market Share Analysis & Forecast
        • 5.3.1.2.1. By Product
          • 5.3.1.2.1.1. Safety Lancets
          • 5.3.1.2.1.2. Standard Lancets
          • 5.3.1.2.1.3. Specialty Lancets
          • 5.3.1.2.1.4. Others
        • 5.3.1.2.2. By Application
          • 5.3.1.2.2.1. Glucose Testing
          • 5.3.1.2.2.2. Hemoglobin Testing
          • 5.3.1.2.2.3. Cholesterol Testing
          • 5.3.1.2.2.4. Coagulation Testing
          • 5.3.1.2.2.5. Others
        • 5.3.1.2.3. By Age Group
          • 5.3.1.2.3.1. Adults
          • 5.3.1.2.3.2. Pediatric
        • 5.3.1.2.4. By End-user
          • 5.3.1.2.4.1. Hospitals
          • 5.3.1.2.4.2. Clinics
          • 5.3.1.2.4.3. Diagnostic Centers
          • 5.3.1.2.4.4. Home Care Settings
          • 5.3.1.2.4.5. Others
    • 5.3.2. Canada
    • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Lancets Market Outlook, 2017-2031F

  • 6.1. Germany
  • 6.2. France
  • 6.3. Italy
  • 6.4. United Kingdom
  • 6.5. Russia
  • 6.6. Netherlands
  • 6.7. Spain
  • 6.8. Poland

7. Asia-Pacific Lancets Market Outlook, 2017-2031F

  • 7.1. India
  • 7.2. China
  • 7.3. Japan
  • 7.4. Australia
  • 7.5. Vietnam
  • 7.6. South Korea
  • 7.7. Indonesia
  • 7.8. Philippines

8. South America Lancets Market Outlook, 2017-2031F

  • 8.1. Brazil
  • 8.2. Argentina

9. Middle East and Africa Lancets Market Outlook, 2017-2031F

  • 9.1. Saudi Arabia
  • 9.2. UAE
  • 9.3. South Africa
  • 9.4. Israel

10. Demand Supply Analysis

11. Value Chain Analysis

12. Porter's Five Forces Analysis

13. PESTLE Analysis

14. Pricing Analysis

15. Market Dynamics

  • 15.1. Market Drivers
  • 15.2. Market Challenges

16. Market Trends and Developments

17. Regulatory Framework and Innovation

  • 17.1. Clinical Trials
  • 17.2. Regulatory Approvals

18. Patent Landscape

19. Case Studies

20. Competitive Landscape

  • 20.1. Competition Matrix of Top 5 Market Leaders
  • 20.2. SWOT Analysis for Top 5 Players
  • 20.3. Key Players Landscape for Top 10 Market Players
    • 20.3.1. HTL-Strefa S.A.
      • 20.3.1.1. Company Details
      • 20.3.1.2. Key Management Personnel
      • 20.3.1.3. Products and Services
      • 20.3.1.4. Financials (As Reported)
      • 20.3.1.5. Key Market Focus and Geographical Presence
      • 20.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
    • 20.3.2. Terumo Medical Corporation
    • 20.3.3. Becton Dickinson and Company
    • 20.3.4. F.Hoffman-La Roche AG
    • 20.3.5. B.Braun SE
    • 20.3.6. Abbott Laboratories
    • 20.3.7. Owen Mumford Ltd.
    • 20.3.8. Arkray Inc
    • 20.3.9. Bayer AG
    • 20.3.10. Medline Industries, LP

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

21. Strategic Recommendations

22. About Us and Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 3. Global Lancets Market Share (%), By Product, 2017-2031F
  • Figure 4. Global Lancets Market Share (%), By Application, 2017-2031F
  • Figure 5. Global Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 6. Global Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 7. Global Lancets Market Share (%), By Region, 2017-2031F
  • Figure 8. North America Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 9. North America Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 10. North America Lancets Market Share (%), By Product, 2017-2031F
  • Figure 11. North America Lancets Market Share (%), By Application, 2017-2031F
  • Figure 12. North America Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 13. North America Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 14. North America Lancets Market Share (%), By Country, 2017-2031F
  • Figure 15. United States Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 16. United States Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 17. United States Lancets Market Share (%), By Product, 2017-2031F
  • Figure 18. United States Lancets Market Share (%), By Application, 2017-2031F
  • Figure 19. United States Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 20. United States Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 21. Canada Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 22. Canada Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 23. Canada Lancets Market Share (%), By Product, 2017-2031F
  • Figure 24. Canada Lancets Market Share (%), By Application, 2017-2031F
  • Figure 25. Canada Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 26. Canada Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 27. Mexico Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 28. Mexico Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 29. Mexico Lancets Market Share (%), By Product, 2017-2031F
  • Figure 30. Mexico Lancets Market Share (%), By Application, 2017-2031F
  • Figure 31. Mexico Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 32. Mexico Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 33. Europe Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 34. Europe Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 35. Europe Lancets Market Share (%), By Product, 2017-2031F
  • Figure 36. Europe Lancets Market Share (%), By Application, 2017-2031F
  • Figure 37. Europe Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 38. Europe Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 39. Europe Lancets Market Share (%), By Country, 2017-2031F
  • Figure 40. Germany Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 41. Germany Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 42. Germany Lancets Market Share (%), By Product, 2017-2031F
  • Figure 43. Germany Lancets Market Share (%), By Application, 2017-2031F
  • Figure 44. Germany Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 45. Germany Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 46. France Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 47. France Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 48. France Lancets Market Share (%), By Product, 2017-2031F
  • Figure 49. France Lancets Market Share (%), By Application, 2017-2031F
  • Figure 50. France Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 51. France Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 52. Italy Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 53. Italy Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 54. Italy Lancets Market Share (%), By Product, 2017-2031F
  • Figure 55. Italy Lancets Market Share (%), By Application, 2017-2031F
  • Figure 56. Italy Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 57. Italy Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 58. United Kingdom Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 59. United Kingdom Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 60. United Kingdom Lancets Market Share (%), By Product, 2017-2031F
  • Figure 61. United Kingdom Lancets Market Share (%), By Application, 2017-2031F
  • Figure 62. United Kingdom Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 63. United Kingdom Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 64. Russia Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 65. Russia Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 66. Russia Lancets Market Share (%), By Product, 2017-2031F
  • Figure 67. Russia Lancets Market Share (%), By Application, 2017-2031F
  • Figure 68. Russia Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 69. Russia Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 70. Netherlands Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 71. Netherlands Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 72. Netherlands Lancets Market Share (%), By Product, 2017-2031F
  • Figure 73. Netherlands Lancets Market Share (%), By Application, 2017-2031F
  • Figure 74. Netherlands Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 75. Netherlands Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 76. Spain Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 77. Spain Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 78. Spain Lancets Market Share (%), By Product, 2017-2031F
  • Figure 79. Spain Lancets Market Share (%), By Application, 2017-2031F
  • Figure 80. Spain Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 81. Spain Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 82. Turkey Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 83. Turkey Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 84. Turkey Lancets Market Share (%), By Product, 2017-2031F
  • Figure 85. Turkey Lancets Market Share (%), By Application, 2017-2031F
  • Figure 86. Turkey Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 87. Turkey Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 88. Poland Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 89. Poland Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 90. Poland Lancets Market Share (%), By Product, 2017-2031F
  • Figure 91. Poland Lancets Market Share (%), By Application, 2017-2031F
  • Figure 92. Poland Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 93. Poland Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 94. South America Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 95. South America Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 96. South America Lancets Market Share (%), By Product, 2017-2031F
  • Figure 97. South America Lancets Market Share (%), By Application, 2017-2031F
  • Figure 98. South America Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 99. South America Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 100. South America Lancets Market Share (%), By Country, 2017-2031F
  • Figure 101. Brazil Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 102. Brazil Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 103. Brazil Lancets Market Share (%), By Product, 2017-2031F
  • Figure 104. Brazil Lancets Market Share (%), By Application, 2017-2031F
  • Figure 105. Brazil Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 106. Brazil Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 107. Argentina Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 108. Argentina Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 109. Argentina Lancets Market Share (%), By Product, 2017-2031F
  • Figure 110. Argentina Lancets Market Share (%), By Application, 2017-2031F
  • Figure 111. Argentina Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 112. Argentina Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 113. Asia-Pacific Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 114. Asia-Pacific Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 115. Asia-Pacific Lancets Market Share (%), By Product, 2017-2031F
  • Figure 116. Asia-Pacific Lancets Market Share (%), By Application, 2017-2031F
  • Figure 117. Asia-Pacific Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 118. Asia-Pacific Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 119. Asia-Pacific Lancets Market Share (%), By Country, 2017-2031F
  • Figure 120. India Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 121. India Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 122. India Lancets Market Share (%), By Product, 2017-2031F
  • Figure 123. India Lancets Market Share (%), By Application, 2017-2031F
  • Figure 124. India Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 125. India Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 126. China Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 127. China Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 128. China Lancets Market Share (%), By Product, 2017-2031F
  • Figure 129. China Lancets Market Share (%), By Application, 2017-2031F
  • Figure 130. China Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 131. China Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 132. Japan Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 133. Japan Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 134. Japan Lancets Market Share (%), By Product, 2017-2031F
  • Figure 135. Japan Lancets Market Share (%), By Application, 2017-2031F
  • Figure 136. Japan Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 137. Japan Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 138. Australia Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 139. Australia Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 140. Australia Lancets Market Share (%), By Product, 2017-2031F
  • Figure 141. Australia Lancets Market Share (%), By Application, 2017-2031F
  • Figure 142. Australia Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 143. Australia Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 144. Vietnam Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 145. Vietnam Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 146. Vietnam Lancets Market Share (%), By Product, 2017-2031F
  • Figure 147. Vietnam Lancets Market Share (%), By Application, 2017-2031F
  • Figure 148. Vietnam Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 149. Vietnam Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 150. South Korea Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 151. South Korea Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 152. South Korea Lancets Market Share (%), By Product, 2017-2031F
  • Figure 153. South Korea Lancets Market Share (%), By Application, 2017-2031F
  • Figure 154. South Korea Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 155. South Korea Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 156. Indonesia Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 157. Indonesia Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 158. Indonesia Lancets Market Share (%), By Product, 2017-2031F
  • Figure 159. Indonesia Lancets Market Share (%), By Application, 2017-2031F
  • Figure 160. Indonesia Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 161. Indonesia Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 162. Philippines Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 163. Philippines Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 164. Philippines Lancets Market Share (%), By Product, 2017-2031F
  • Figure 165. Philippines Lancets Market Share (%), By Application, 2017-2031F
  • Figure 166. Philippines Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 167. Philippines Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 168. Middle East & Africa Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 169. Middle East & Africa Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 170. Middle East & Africa Lancets Market Share (%), By Product, 2017-2031F
  • Figure 171. Middle East & Africa Lancets Market Share (%), By Application, 2017-2031F
  • Figure 172. Middle East & Africa Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 173. Middle East & Africa Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 174. Middle East & Africa Lancets Market Share (%), By Country, 2017-2031F
  • Figure 175. Saudi Arabia Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 176. Saudi Arabia Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 177. Saudi Arabia Lancets Market Share (%), By Product, 2017-2031F
  • Figure 178. Saudi Arabia Lancets Market Share (%), By Application, 2017-2031F
  • Figure 179. Saudi Arabia Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 180. Saudi Arabia Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 181. UAE Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 182. UAE Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 183. UAE Lancets Market Share (%), By Product, 2017-2031F
  • Figure 184. UAE Lancets Market Share (%), By Application, 2017-2031F
  • Figure 185. UAE Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 186. UAE Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 187. South Africa Lancets Market, By Value, In USD Billion, 2017-2031F
  • Figure 188. South Africa Lancets Market, By Volume, In Million Units, 2017-2031F
  • Figure 189. South Africa Lancets Market Share (%), By Product, 2017-2031F
  • Figure 190. South Africa Lancets Market Share (%), By Application, 2017-2031F
  • Figure 191. South Africa Lancets Market Share (%), By Age Group, 2017-2031F
  • Figure 192. South Africa Lancets Market Share (%), By End-user, 2017-2031F
  • Figure 193. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 194. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 195. By Age Group Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 196. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023